Increased use of diagnostic testing after increased nuchal translucency: The influence of non‐invasive prenatal testing and chromosomal microarray
- 7 November 2022
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 42 (13) , 1606-1611
Abstract
Objective: The utilization of non‐invasive prenatal testing (NIPT) and chromosomal microarray (CMA) has significantly altered the options for testing following the diagnosis of an increased nuchal translucency (NT). This study defines the rates of utilization of diagnostic testing in the pre‐NIPT, pre‐CMA, and post‐CMA eras.Methods: We retrospectively examined NT scans performed in our department from January 2010 to December 2020 and identified all NTs ≥3.0 mm for analysis. We divided our data into three distinct periods (2010–2012, 2013–2016, and 2017–2020) corresponding to our institutional practice shifts in recommending and offering use of NIPT (2013) and CMA (2016), respectively.Results: 689 patients with NT ≥ 3.0 mm met inclusion criteria in our study, of which 355 (51.5%) individuals underwent diagnostic testing and 334 (48.5%) did not. There was a significant decline in rates of diagnostic testing with NIPT (2013), which has returned to pre‐NIPT levels with the availability of microarray.Conclusions: Since the routine use of CMA (2016), the rates of diagnostic testing for increased NT have returned to pre‐NIPT levels. This study validates data suggesting an initial decline in the rates of diagnostic testing following abnormal NT but suggests that the decline may be reversing in the post‐CMA era due to a rise in rates of chorionic villus sampling.Keywords
This publication has 15 references indexed in Scilit:
- Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015Australian and New Zealand Journal of Obstetrics and Gynaecology, 2017
- Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and GynecologyObstetrics & Gynecology, 2016
- Practice Bulletin No. 163Obstetrics & Gynecology, 2016
- Practice Bulletin No. 162Obstetrics & Gynecology, 2016
- Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screeningPrenatal Diagnosis, 2013
- The Associations of Nuchal Translucency and Fetal Abnormalities; Significance and ImplicationsJournal of Clinical and Diagnostic Research, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Committee Opinion No. 545Obstetrics & Gynecology, 2012
- Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotypeUltrasound in Obstetrics & Gynecology, 2011
- Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational studyBMJ, 2006